Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence

Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence

In recent years, the treatment landscape of urothelial carcinoma has significantly changed due to the introduction of immune checkpoint inhibitors (ICIs), which are the standard of care for second-line treatment and first-line platinum-ineligible patients with advanced disease. Despite the overall s...

Full description

Saved in:
Bibliographic Details
Main Authors: Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, Alessandra Damassi, Emilio Francesco Giunta, Filippo Fraggetta, Ugo De Giorgi, Richard Cathomas, Pasquale Rescigno, Matteo Brunelli, Giuseppe Fornarini
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
advanced urothelial carcinoma
immune checkpoint inhibitor
immunotherapy
prognostic
biomarkers
tumour mutational board
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/fa29ae1e6f13459d8ecd55cb63cd1b64
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/fa29ae1e6f13459d8ecd55cb63cd1b64

Similar Items